Florida Pharmacist Sentenced to Over 7 Years for Massive Oxycodone Distribution Conspiracy

What this means for your practice

This enforcement action by the Department of Justice, involving the DEA, FBI, and HHS-OIG, serves as a critical reminder for all healthcare businesses—including telehealth providers, medspas, dental practices, and chiropractors—about the severe consequences of controlled substance diversion and inadequate dispensing practices. While this case involves a pharmacist, the underlying principles of medical necessity, legitimate patient-prescriber relationships, and adherence to dispensing regulations apply universally. Practices involved in prescribing or dispensing controlled substances must maintain rigorous compliance protocols, including thorough patient evaluations, proper documentation, and vigilance against 'red flags' such as cash-only payments, patients traveling long distances for prescriptions, or individuals attempting to obtain drugs for others. This case underscores the DOJ's intensified focus on healthcare fraud, particularly involving opioids, signaling a heightened enforcement environment for any provider whose practices deviate from established medical standards.

The Department of Justice (DOJ) announced a significant enforcement action against a Florida pharmacist and pharmacy owner, Olushola Yusuf, 60, of Tampa. Yusuf was sentenced to 90 months (7 years and 6 months) in prison for her pivotal role in an extensive conspiracy to illegally distribute over 300,000 oxycodone 30mg pills to individuals who lacked medical necessity for the powerful opioid.

The Illicit Scheme Unveiled

According to court documents and evidence presented during a two-week trial in July 2026, Ms. Yusuf systematically dispensed oxycodone 30mg to nearly all of her pharmacy customers. This occurred at the two pharmacies she owned and operated: Boots LLC, doing business as Striderite in Margate, and Chans Pharmacy Plus, Inc. in Pembroke Pines, Florida.

The investigation revealed a sophisticated yet brazen operation designed to profit from illicit drug distribution. Yusuf charged customers approximately 10 times the typical cost of the drug, exclusively demanding cash payments, with some customers paying as much as $1,300 per month. The high volume of dispensing involved at least 335,351 pills of oxycodone 30mg, a maximum strength opioid typically reserved for seriously ill patients suffering from chronic cancer pain or traumatic injuries due to its potency and potential for danger.

Witness testimony at trial painted a picture of a clandestine operation. Customers, some of whom were identified as drug dealers, traveled long distances to fill prescriptions that other legitimate pharmacies would not. These individuals often picked up oxycodone pills purportedly on behalf of dozens of absent patients. Yusuf maintained a tightly controlled environment within her pharmacies, keeping the doors locked during business hours and instructing employees to only open for specific, identified customers.

Critically, Ms. Yusuf continued her illicit dispensing activities even after receiving repeated warnings from both her employees and the Drug Enforcement Administration (DEA) regarding the perilous nature of her pharmacy operations. Her disregard for these warnings and regulatory compliance ultimately led to her conviction.

Conviction and Co-Defendant

Following the trial, a jury found Yusuf guilty of conspiracy to illegally distribute drugs and five separate counts of illegal drug distribution. Her co-defendant, Saman Gimenez, previously pleaded guilty to conspiracy to illegally distribute drugs and is awaiting sentencing.

Interagency Collaboration and Broader Enforcement Context

This successful prosecution was the result of a collaborative effort by multiple federal agencies. The announcement was made by Assistant Attorney General Colin M. McDonald of the Justice Department’s National Fraud Enforcement Division, U.S. Attorney Jason A. Reding Quiñones for the Southern District of Florida, DEA Chief of Operations Matthew W. Allen, FBI Co-Deputy Director Christopher Raia, and Acting Deputy Inspector General for Investigations Miranda L. Bennett for the Department of Health and Human Services, Office of Inspector General (HHS OIG). The case was investigated by the DEA, FBI, and HHS-OIG, and prosecuted by Trial Attorney Angela Benoit of the Fraud Division’s Health Care Fraud Section and Assistant U.S. Attorney Jacqueline DerOvanesian for the Southern District of Florida.

This case highlights the broader enforcement priorities of the Department of Justice. The DOJ recently announced the creation of its Fraud Division, which is specifically tasked with investigating and prosecuting individuals who commit fraud against the American people. This initiative aligns with President Trump’s Task Force to Eliminate Fraud, a whole-of-government effort aimed at eliminating fraud, waste, and abuse within federal benefit programs.

The Department of Justice’s Health Care Fraud Strike Force Program, operating in federal districts nationwide, has been instrumental in combating healthcare fraud. Since 2007, these strike forces have charged over 6,200 defendants, who collectively billed federal healthcare programs and private insurers more than $45 billion. Furthermore, the Centers for Medicare & Medicaid Services (CMS), in collaboration with HHS-OIG, is actively working to hold providers accountable for their involvement in healthcare fraud schemes.

More information on the DOJ’s efforts to combat healthcare fraud can be found at www.justice.gov/fraud/health-care-fraud-section.

Source: https://www.justice.gov/opa/pr/florida-pharmacist-sentenced-over-7-years-prison-massive-illegal-oxycodone-distribution

Key Facts

Frequently Asked Questions

What was the Florida pharmacist, Olushola Yusuf, sentenced for?

Olushola Yusuf was sentenced for her role in illegally dispensing over 300,000 oxycodone 30mg pills to pharmacy customers who had no medical need for the drug, and for conspiracy to illegally distribute drugs and five counts of illegal drug distribution.

What was unusual about the way Ms. Yusuf operated her pharmacies?

Ms. Yusuf charged approximately 10 times the typical cost for oxycodone, required cash payments, kept her pharmacy doors locked during business hours opening only for certain customers, and dispensed high-strength oxycodone to customers, some of whom were drug dealers, who often drove long distances and could not get prescriptions filled elsewhere.

Which federal agencies were involved in the investigation and prosecution of this case?

The case was investigated by the Drug Enforcement Administration (DEA), the Federal Bureau of Investigation (FBI), and the Department of Health and Human Services, Office of Inspector General (HHS-OIG). It was prosecuted by the Department of Justice’s National Fraud Enforcement Division and the U.S. Attorney’s Office for the Southern District of Florida.

What is the significance of oxycodone 30mg?

Oxycodone 30mg is the maximum strength available of the drug. It is considered potent and potentially dangerous, typically prescribed only to seriously ill patients, such as those suffering from chronic cancer pain or traumatic injuries.

Source: DOJ — Florida Pharmacist Sentenced to Over 7 Years in Prison for Massive Illegal Oxycodone Distribution Conspiracy · Fri, 30 Oct 2026 12:00:00 +0000